Company Filing History:
6 out of 1,327 
6 out of 17 
1 out of 832,891 Years Active: 2000-2009
Title: The Innovative Spirit of Kenneth Brooks Low
Introduction: Kenneth Brooks Low is an accomplished inventor based in Guilford, CT, known for his groundbreaking work in the field of biotechnology. With an impressive portfolio of nine patents, he has made notable contributions to the development of genetically modified organisms aimed at combating cancer.
Latest Patents: Among his latest inventions, Kenneth has pioneered genetically modified tumor-targeted bacteria with reduced virulence. This innovative approach involves mutant strains possessing a genetically modified msbB gene, which allows them to effectively target solid tumors. Additionally, his invention incorporates modifications in a biosynthetic pathway gene, such as the purl gene, further enhancing its therapeutic potential for inhibiting growth and reducing the volume of solid tumors.
Career Highlights: Kenneth has had a dynamic career, with significant tenures at prestigious institutions such as Yale University and Vion Pharmaceuticals, Inc. His work in these organizations has facilitated the advancement of cancer treatment methodologies and has established him as a key figure in the field.
Collaborations: Throughout his professional journey, Kenneth has collaborated with leading scientists, including David Gordon Bermudes and John M. Pawelek. These partnerships have not only enriched his research but have also fostered innovation in biotechnology and cancer therapeutics.
Conclusion: Kenneth Brooks Low's contributions to the field of cancer research through his patented inventions reflect a commitment to harnessing innovation for improved health outcomes. His work exemplifies the vital role that inventors play in addressing complex medical challenges, paving the way for future advancements in cancer treatment.